Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud D Roth

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Diseases of the Colon and Rectum|April 8, 2011
Successful closure of anal cancer-related fistulas with upfront intra-arterial chemotherapy: a report of 8 casesRobert Kridel, Stéphane Cochet, Bruno Roche, et al.
Swiss Medical Weekly|August 27, 2011
Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancerPierre Bohanes, Delphine S Courvoisier, Thomas V Perneger, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective studyAbdelkarim S Allal, Pascal Gervaz, Philippe Gertsch, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2013
Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional controlThomas Zilli, Michael Betz, Sabine Bieri, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2005
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trialAbdelkarim S Allal, Daniel Zwahlen, Marie-Anne Bründler, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trialAbdelkarim S Allal, Sabine Bieri, Pascal Gervaz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trialAbdelkarim S Allal, Sabine Bieri, Marie-Anne Bründler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2018
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trialSabine Tejpar, Pu Yan, Hubert Piessevaux, et al.
Digestive Surgery|February 13, 2009
'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastasesGilles Mentha, Arnaud D Roth, Sylvain Terraz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 studyGertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Diseases of the Colon and Rectum|April 8, 2011
Successful closure of anal cancer-related fistulas with upfront intra-arterial chemotherapy: a report of 8 casesRobert Kridel, Stéphane Cochet, Bruno Roche, et al.
Swiss Medical Weekly|August 27, 2011
Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancerPierre Bohanes, Delphine S Courvoisier, Thomas V Perneger, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective studyAbdelkarim S Allal, Pascal Gervaz, Philippe Gertsch, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2013
Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional controlThomas Zilli, Michael Betz, Sabine Bieri, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2005
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trialAbdelkarim S Allal, Daniel Zwahlen, Marie-Anne Bründler, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trialAbdelkarim S Allal, Sabine Bieri, Pascal Gervaz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trialAbdelkarim S Allal, Sabine Bieri, Marie-Anne Bründler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2018
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trialSabine Tejpar, Pu Yan, Hubert Piessevaux, et al.
Digestive Surgery|February 13, 2009
'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastasesGilles Mentha, Arnaud D Roth, Sylvain Terraz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 studyGertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
Pageof 4